Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00050960

Femme et Homme

Extrait

This study evaluates the use of Targretin capsules (bexarotene) in combination with standard chemotherapy for the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in patients who have not yet received chemotherapy for their lung cancer.


Critère d'inclusion

  • non-small cell lung cancer


Liens